Studies have shown that GPRC5A is a potential biomarker for colon cancer and promotes the occurrence of tumors in colitis-associated cancers by stimulating vanin-1 expression and oxidative stress [16]. This evidence concerns the gene VNN1 and colonic neoplasm.